Steroid resistance in asthma: Our current understanding

Publisher Website
Google Scholar
Abstract
While much information has recently been obtained regarding the features of steroid‐resistant asthma, it continues to be a dilemma for practitioners, and investigation into its mechanisms will remain an important part of asthma research. Until a clear marker defining steroid‐resistant asthmatics is found, the principle first put forth by Carmichael and colleagues6 should be adhered to: that is, asthmatics resistant to glucocorticoid therapy need to be identified at an early stage so that unnecessary and perhaps harmful therapy can be discontinued. A 10 day course of high‐dose (≥30 mg/day) systemic glucocorticoid therapy, as suggested by Kamada and colleagues,11 may constitute an adequate trial and may sufficiently identify asthmatics who may require alternative treatments. A more rational approach to the selection of alternative asthma treatments will be gained when the mechanisms of steroid resistance are identified.